Pembrolizumab vs Simvastatin

## Pembrolizumab vs Simvastatin: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Simvastatin**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Simvastatin**: Prodrug converted to active form that inhibits HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Simvastatin — 2 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Simvastatin — C25H38O5.

**Molecular Weight**: Pembrolizumab — N/A; Simvastatin — 418.5700 g/mol.

**Type**: Pembrolizumab — Antibody; Simvastatin — Small molecule.